Skip to Main Content

++

IX.C.001 Precursor T-Cell Acute Lymphoblastic Leukemia/Lymphoma

++
Graphic Jump Location

IX.C.001

Precursor T-cell acute lymphoblastic leukemia/lymphoma. Flow cytometry. Staining pattern seen in a marrow cells from a patient with acute lymphoblastic leukemia/lymphoma, precursor T-cell type. The upper left panel shows the pattern of leukocyte common antigen (CD45) versus side-scatter analysis. Lymphoblasts have slightly dimmer CD45 staining than mature lymphocytes but merges with the normal lymphocyte population. The upper middle and upper right panels show that the bright CD45+ population (indicated by R1 and shown in red on gated graphs) contains a subpopulation of cells that are negative for surface CD3 and surface CD19 but co-express CD4 and CD8 (a common thymocyte phenotype). In this case, the CD4+/CD8+ population accounts for approximately 26% of all cells in the marrow. The lower row of dot plots indicates that this population is surface CD3 negative, surface CD5 positive, surface CD7 positive, and co-expresses cytoplasmic CD3 and terminal deoxynucleotidyl transferase (TdT). TdT is a nuclear antigen, but can be assessed by flow cytometry using permeabilization methods that are also used for assessing cytoplasmic marker staining (cellular fixation in formalin, followed by incubation of antibody with cells in a very weak detergent solution).

++

IX.C.002 Acute Lymphoblastic Leukemia, Precursor B-Cell Phenotype

++
Graphic Jump Location

IX.C.002

Acute lymphoblastic leukemia, precursor B-cell phenotype. Flow cytometry. Staining pattern of leukocytes of a pediatric precursor B-cell acute lymphoblastic leukemia. Analysis of blood cells shows a prominent CD19+/CD10+ population (upper left plot). Gating for this population based on CD45 vs. side-scatter showed bright CD19 staining and lack of surface CD3 and absence of either surface kappa or lambda expression (upper middle and upper right plots). In the lower row are prototypical cytoplasmic staining findings. In conjunction with surface CD19 staining (y-axis), blasts show co-expression of cytoplasmic CD22 and terminal deoxynucleotidyl transferase (TdT), but lack of myeloperoxidase (MPO) staining using an anti-MPO antibody. Blasts on the blood film were also negative on cytochemistry stain for myeloperoxidase activity.

++

IX.C.003 Chronic Lymphocytic Leukemia–Small Lymphocytic Lymphoma

++
Graphic Jump Location

IX.C.003

Chronic lymphocytic leukemia–small lymphocytic lymphoma. Flow cytometry. Staining of lymph node cell suspension. Gating for CD19+ B-cells shows a clonal, kappa-restricted B cell population with co-expression of CD20, CD5, and CD23.

++

IX.C.004 Chronic Lymphocytic Leukemia–Small Lymphocytic Lymphoma-CD38

++
Graphic Jump Location

IX.C.004

Chronic lymphocytic leukemia–small lymphocytic lymphoma-CD38. Flow cytometry. Gating for the dual CD19+/CD5+ lymphocyte population shows that virtually all lymphocytes in this case co-express the activation marker CD38, which is considered to be an adverse prognostic indicator predicting for CLL progression.

++

IX.C.005 Chronic Lymphocytic Leukemia (CLL)–Small Lymphocytic Lymphoma (SLL)–Zap 70

++

Want remote access to your institution's subscription?

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.

Ok

About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.